
The Impact You’ll Make
Recursion is at the forefront of reimagining drug discovery and development through broadening the funnel of potential targets, using technology and standardization to build connected data. As a research scientist in the primary pharmacology department you will design, plan and execute a variety of experiments ensuring that the assays are fit-for-purpose, and that data is appropriately quality-controlled. In our new, state-of-the-art laboratories, you will utilize a wide array of assay technologies and automation capabilities. We are committed to deploying the latest advancements and optimising processes for quality and efficiency. You will leverage your scientific and cell-based expertise to design and implement experiments, driving our drug discovery projects forward.
In this role, you will:
The Team You’ll Join
You will join the Primary Pharmacology team, who are based in Milton Park, Abingdon, at Recursion. The Primary Pharmacology team is a group of project-facing biochemists and cell biology scientists that support drug discovery projects from target validation to candidate selection. Core functions within this team include assay development, HTS, routine screening, cell culture, and automation.
The Experience You’ll Need
Working Location & Compensation:
This is a lab-based role in our Milton Park site. Employees are expected to work on-site most of the time, with occasional flexibility.
At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is £41,000 to £52,000 You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.
#LI-BO1
The Values We Hope You Share:
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area.
Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.